3D1002
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 3D1002, covering 2026-03-11 to 2026-03-11. Get the full timeline:
Most recent: Clinical Trial Update: 3D1002 in Combination With Oxycodone Hydrochloride Sustained-release Tablets in Patients With Moderate to Severe Cancer Pain [Phase 2]